MEDPOINT
LIVE

Serial Number

88507409

Owner

Medpoint Communications, Inc.

Attorney

John L. Ambrogi

First Use Date

Aug 29, 2011

Filing Date

Jul 10, 2019

Add to watchlist:

No watchlists yet
View on USPTO

MEDPOINT Trademark

Serial Number: 88507409 • Registration: 6278614

MEDPOINT is a trademark filed by Medpoint Communications, Inc. on July 10, 2019. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Medpoint Communications, Inc. (21 trademarks)

Suite 500
Evanston, IL 60201

Entity Type: 03

Trademark Details

Filing Date

July 10, 2019

Registration Date

February 23, 2021

First Use Anywhere

August 29, 2011

First Use in Commerce

August 29, 2011

Published for Opposition

April 21, 2020

Goods & Services

Training and support services, namely, live digital training events, web site-based training modules, and web site-based training management center featuring instruction in the field of digital media support for clinical research; and training clinical research raters in the use of digital and web site-based systems

Providing digital technology services, namely, Software as a Service services featuring a software platform for providing users access to documents, training, messages, alerts, forms, and related materials in the field of medical and scientific research information and clinical trials, and computer services that provide web facilities, namely, a web-based system in the nature of online non-downloadable software and online portal in the field of medical and scientific research information and clinical trials that provides users access to documents, training, messages, alerts, forms, and related materials; hosting secure, audit-ready compliant online web facilities for others for organizing and conducting online meetings, gatherings, and interactive discussions for the biopharma industry, namely, providing a website featuring technology that enables clinical research associates to monitor investigative sites that are conducting clinical trials by means of live virtual meetings; providing an online non-downloadable live virtual meeting software platform to support remote, digital patient visits to investigator sites in the course of clinical trials for medicines and medical products by providing a website with technology that allows health care professional speakers to hold digital online meetings for virtual events over the internet, that allows users to hold virtual speaking events and advisory and pharmaceutical webcasts, that allows health care professionals to conduct virtual and online digital advisory and consulting meetings, that allows uses to conduct virtual and online digital pharmaceutical and biotech training events, that allows uses to conduct and online digital speaking and virtual peer-to-peer programs; providing online non-downloadable computer software for document management processes for product marketing, commercialization, medical affairs and clinical research for medical product, pharmaceutical and biotechnology companies, for clinical trial document and records exchange and access which includes providing a hosted website portal in the nature of an online computer database featuring online information in the field of healthcare for use by healthcare professionals engaged in commercialization of medical products; providing online non-downloadable software for providing access to a portal that provides patients with information regarding clinical trials and allows them to stay connected and in control of their role as participants in clinical trials; providing support services, namely, computer programming, customizing computer software, system analysis and design for document management processes for product marketing, commercialization, medical affairs and clinical research, for medical product, pharmaceutical and biotechnology companies

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 23, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 23, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 19, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 18, 2021 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 8, 2021 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Jan 7, 2021 SUPC
SOU EXTENSION 1 GRANTED
Jan 7, 2021 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 4, 2021 AITU
USE AMENDMENT FILED
Dec 15, 2020 IUAF
SOU EXTENSION 1 FILED
Dec 15, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 15, 2020 EEXT
TEAS STATEMENT OF USE RECEIVED
Dec 15, 2020 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 16, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 21, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 10, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 10, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 10, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 10, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 20, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2020 CRFA
ASSIGNED TO LIE
Feb 20, 2020 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 14, 2020 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 14, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 26, 2019 GNRN
NON-FINAL ACTION E-MAILED
Sep 26, 2019 GNRT
NON-FINAL ACTION WRITTEN
Sep 26, 2019 CNRT
ASSIGNED TO EXAMINER
Sep 26, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 17, 2019 NWOS
NEW APPLICATION ENTERED
Jul 13, 2019 NWAP